Seth Orlow

Director/Miembro de la Junta en ALMIRALL, S.A. .

Health Technology

Consumer Services

Finance

Perfil

Seth J.
Orlow was the founder of Ivrea Pharmaceuticals, Inc., founded in 2005, where the title held was Director.
Dr. Orlow is also the founder of Anaderm Research Corp...
Dr. Orlow currently serves as Independent Director at Almirall SA since 2016.
Dr. Orlow is Director at R2 Dermatology, Inc., Director at R2 Technologies, Inc. (California), and Professor at New York University.
Former positions include Director at Coapt Systems, Inc., Director at Protez Pharmaceuticals, Inc., Director at Transave, Inc., Managing Director at Easton Capital Investment Group, Trustee at Dermatology Foundation, Partner at Easton Capital Partners LP, and Professor at Nyu Grossman School of Medicine.
Education includes a doctorate from Albert Einstein College of Medicine, Inc. and an undergraduate degree from Harvard College.

Cargos activos de Seth Orlow

Empresas	Cargo	Inicio
ALMIRALL, S.A.	Director/Miembro de la Junta	01/01/2016
New York University New York University Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
R2 Dermatology, Inc. R2 Dermatology, Inc. Part of Lancer Venture Capital, R2 Dermatology, Inc. is a company specializing in cryoaesthetics medical devices, focusing on advanced cryotherapy-based skin treatments. The company is based in New York, NY. R2 Dermatology develops proprietary cryomodulation technology that uses precision contact cooling to reduce skin inflammation, redness, and signs of premature aging. Its flagship Glacial skin platform includes FDA-cleared and health-licensed devices such as Glacial Rx, a cryosurgical instrument for dermatologic procedures, and Glacial Fx, a compact wellness device. These devices deliver customizable treatments that promote skin regeneration, improve brightness, texture, tone, and hydration, and can be combined with other aesthetic procedures. The Glacial treatment modalities include Gloss Rx, Glide Rx, Glide Rx combinations, and Freeze for benign lesion removal. R2 Dermatology offers the Glacial Peak program, a tiered premium membership for dermatology practices, providing consumables, shipping, warranty coverage, marketing support, provider listings, discounts, certification, and ongoing education. The company maintains a patent portfolio protecting its Glacial line and technologies and targets healthcare providers and patients, offering educational resources and training. The CEO of the company is Gordon E. Nye.	Director/Miembro de la Junta	-
R2 Technologies, Inc. (California) R2 Technologies, Inc. (California) Medical SpecialtiesHealth Technology Develops medical device for age spots	Director/Miembro de la Junta	-

Todos los cargos activos de Seth Orlow

Antiguos cargos conocidos de Seth Orlow.

Empresas	Cargo	Fin
Nyu Grossman School of Medicine Nyu Grossman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
Easton Capital Partners LP Easton Capital Partners LP Investment ManagersFinance Acts as Venture Capital Fund	Corporate Officer/Principal	-
Transave, Inc. Transave, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics to treat chronic respiratory infections	Director/Miembro de la Junta	-
Dermatology Foundation	Director/Miembro de la Junta	-
Anaderm Research Corp.	Fundador	-

Ver el detalle de la experiencia de Seth Orlow.

Formación de Seth Orlow.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Seth Orlow.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	15
Easton Capital Partners LP Easton Capital Partners LP Investment ManagersFinance Acts as Venture Capital Fund	Finance
Coapt Systems, Inc. Coapt Systems, Inc. BiotechnologyHealth Technology Manufactures and markets bioabsorbable implants	Health Technology
Ivrea Pharmaceuticals, Inc. Ivrea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for dermatologic conditions	Health Technology
Almirall SA Almirall SA Pharmaceuticals: MajorHealth Technology Engages in the development, manufacture and sale of pharmaceuticals	Health Technology
Protez Pharmaceuticals, Inc. Protez Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products	Health Technology
New York University New York University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Transave, Inc. Transave, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics to treat chronic respiratory infections	Health Technology
Easton Capital Investment Group Easton Capital Investment Group Investment ManagersFinance Easton invests in all segments of the healthcare industry, including biopharmaceuticals, drug delivery, medical devices and healthcare services. The firm is stage-agnostic and considers opportunities from early-stage venture capital to later-stage growth capital with investment size ranging from $0.05 - $10 million. They are generally not a seed-stage investor.	Finance
Dermatology Foundation
Albert Einstein College of Medicine, Inc. Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Anaderm Research Corp.
Harvard College Harvard College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
R2 Dermatology, Inc. R2 Dermatology, Inc. Part of Lancer Venture Capital, R2 Dermatology, Inc. is a company specializing in cryoaesthetics medical devices, focusing on advanced cryotherapy-based skin treatments. The company is based in New York, NY. R2 Dermatology develops proprietary cryomodulation technology that uses precision contact cooling to reduce skin inflammation, redness, and signs of premature aging. Its flagship Glacial skin platform includes FDA-cleared and health-licensed devices such as Glacial Rx, a cryosurgical instrument for dermatologic procedures, and Glacial Fx, a compact wellness device. These devices deliver customizable treatments that promote skin regeneration, improve brightness, texture, tone, and hydration, and can be combined with other aesthetic procedures. The Glacial treatment modalities include Gloss Rx, Glide Rx, Glide Rx combinations, and Freeze for benign lesion removal. R2 Dermatology offers the Glacial Peak program, a tiered premium membership for dermatology practices, providing consumables, shipping, warranty coverage, marketing support, provider listings, discounts, certification, and ongoing education. The company maintains a patent portfolio protecting its Glacial line and technologies and targets healthcare providers and patients, offering educational resources and training. The CEO of the company is Gordon E. Nye.
R2 Technologies, Inc. (California) R2 Technologies, Inc. (California) Medical SpecialtiesHealth Technology Develops medical device for age spots	Health Technology
Nyu Grossman School of Medicine Nyu Grossman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services